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Abstract.  The v-sis gene is able to transform cells by 
production of a growth factor that is structurally 
related to platelet-derived growth factor. This growth 
factor has been detected in the conditioned media of 
v-sis transformed cells, and is able to stimulate the 
autophosphorylation of the platelet-derived growth fac- 
tor receptor.  We have used the v-sis gene product to 
analyze the role of protein-encoded signals in cell sur- 
face transport. We constructed several gene fusions 
that encode transmembrane forms of the v-sis gene 
product. These membrane-anchored forms of the v-sis 
gene product are properly folded into a  native struc- 
ture, as indicated by their dimerization, glycosylation, 
and NH2-terminal proteolytic processing.  Indirect 
immunofluorescence demonstrated that several of these 
membrane-anchored gene products are transported to 
the cell surface. Removal of the N-linked glycosylation 
site from the v-sis gene product did not prevent cell 
surface transport.  Several of these mutant genes are 
able to induce focus formation in NIH3T3 cells, 
providing further evidence that the membrane-an- 
chored proteins are properly folded. These results 
demonstrate that N-linked glycosylation is not required 
for the cell surface transport of a  protein that is in a 
native, biologically active conformation. These results 
provide a correlation between cell surface expression 
of the membrane-anchored v-sis gene products and 
transformation. 
T 
HE problem of protein sorting and transport in the cell 
is of major importance to cell biology. The current 
model postulates distinct protein-encoded signals that 
govern their sorting and transport (Blobel, 1980). Evidence 
for this model has been obtained from the analysis of the bio- 
synthesis and transport of secretory and integral membrane 
proteins.  These proteins  are  typically synthesized with a 
hydrophobic NH2-terminal leader sequence that serves as a 
signal for their translocation across the membrane of the 
rough  endoplasmic  reticulum  (RER). t  Cleavage  of  the 
leader sequence and the addition of a high mannose oligosac- 
charide to the consensus site for N-linked glycosylation oc- 
cur cotranslationally. Translocation can be halted by the ac- 
tion of a  stop transfer sequence,  typically a  hydrophobic 
stretch of 20 or so amino acids followed by several  charged 
residues (Yost et al., 1983). Successive utilization of leader 
sequences and stop transfer sequences can account for the 
transmembrane orientation of proteins  that have multiple 
membrane  spanning  domains  (Friedlander  and  Blobel, 
1985). 
The signals that direct the further sorting and transport of 
these proteins during their passage from the RER to their 
1. Abbreviations used in this paper:  EGE epidermal growth factor; Endo 
H,  endoglycosidase H;  MuLV,  murine leukemia virus;  PDGF,  platelet- 
derived growth factor; RER,  rough endoplasmic reticulum; SSV, simian 
sarcoma virus; VSV, vesicular stomatitis virus. 
final destination are not understood.  Recent evidence has 
suggested that  N-linked  glycosylation of the  polypeptide 
chain is one signal that allows for the cell surface transport 
of integral membrane proteins. In one example, the G protein 
of vesicular stomatitis virus  (VSV)  was  found to require 
glycosylation at one of its two sites in order for cell surface 
transport (Machamer et al., 1985). Another series of experi- 
ments demonstrated that a  rat growth hormone-G hybrid 
protein also required the addition of an N-linked oligosac- 
charide for transport to the cell surface (Guan and Rose, 
1984; Guan et al.,  1985). However,  one limitation of these 
studies was the inability to assay the proteins for proper fold- 
ing into a native configuration. In this report we have used 
the v-sis gene product as a model system for the study of pro- 
tein transport and sorting mechanism. The facile dimeriza- 
tion of the v-sis gene product and its requirement of dimer- 
ization for biological activity allow in vivo analysis of the 
native conformation of the polypeptide chain. 
The v-sis oncogene was isolated as the transforming gene 
of simian sarcoma virus, (SSV) (Theilen et al., 1971; Devare 
et al., 1983). It contains an env-sis-fused open reading frame 
of 813 nucleotides, encoding a protein of 271  amino acids. 
This protein can be divided into four different regions on the 
basis of the origin of the coding sequences and on the pres- 
ence of a region of homology with the amino acid sequence 
of platelet-derived growth factor (PDGF) (Doolittle et al., 
1983; Waterfield et al.,  1983; Deuel et al.,  1983). The first 
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derived portion of the open reading frame, and contains the 
signal sequence of the env gene product from simian sar- 
coma-associated virus. The second region extends from res- 
idue 52 to a basic dipeptide Lys-Arg at residues 110-111. A 
high rnannose oligosaccharide is added to Asn residue 93 
during the translocation of the nascent polypeptide chain 
across the membrane of the RER (Robbins et al., 1985; Han- 
nink  and  Donoghue,  1986) The  third  region  includes 
residues 112-220, and is 96% identical to the amino acid se- 
quence of the B chain of human PDGF (Johnsson et al., 
1984). A total of eight cysteine residues are found within this 
region, and dimerization is required for the biological activ- 
ity of both the v-sis gene product and PDGF (Owen et al., 
1984; King et al., 1985; Hannink et al., 1986). The minimal 
transforming region  of the  v-sis  gene  product  is  located 
within this region, consisting of 88 amino acids from residue 
127 to 214 (Saner et al., 1986). The fourth region of the v-sis 
gene product consists of the COOH-terminal 51  residues, 
221-271. These are conserved with respect to the predicted 
amino acid sequence of the human c-sis gene product, but 
are not found in the amino acid sequence of PDGF (Josephs 
et al.,  1984). 
In this study we have constructed mutants of the v-sis gene 
in which a coding region for a membrane anchor domain is 
fused to the v-sis gene. These gene fusions result in the con- 
version of the v-sis gene product from a secretory protein to 
an integral membrane protein. Our results demonstrate that 
the addition of a COOH-terminal transmembrane domain to 
a secretory protein does not interfere with proper folding of 
the polypeptide chain. Furthermore, a membrane-anchored 
v-sis gene product is transported to the cell surface in the ab- 
sence of N-linked glycosylation. Finally, these results sug- 
gest that the membrane-anchored v-sis gene products must 
be transported to the cell surface in order to manifest their 
transforming potential. 
Materials and Methods 
Construction of the v-sis-G Fusions 
The v-sis gene was cloned into a pBR322 derivative, pMH100, in which the 
v-sis coding sequences have a unique XhoI site at their 3' end. This plasmid 
was digested with BstEII, and the 5' overhang was filled in with the Klenow 
fragment of  Escherichia  coli DNA polymerase I and the four deoxynucleo- 
side triphosphates. The plasmid was then re,  cut with XhoI, and the large 
fragment containing the bacterial vector sequences and the 5' end of  the v-sis 
gene was isolated. An AluI to XhoI fragment, containing the coding se- 
quences for the COOH-tt~-minal  49 amino acids of the G protein, was iso- 
lated from pSVGL (Rose and Bergnmnn, 1982) and ligated into the v-sis 
fragment. The blunt-end ligafion between the filled in BstEII site and the 
Alul site restores the BstEII site, and maintains the correct reading frame 
across the junction. The resulting plasmid, pMHI07,  encoded the v-sis  2~- 
G gene. The v-sis239-Cr  ~ gene was constructed in a similar fashion, except 
that the AluI to  XhoI fragment was  from pSVGL  TM  (Adams and  Rose, 
1985). 
In order to construct the v-sis223-G gene, pMHI00 was digested with 
Sinai and XhoI, followed by ligatiun of the AluI to XhoI fragment from 
pSVGL.  To  construct the v-sis239-Cd  ~  gene, pSVGL was digested with 
KpnI, followed by treatment with Klenow fragment and the d¢oxynucl¢o- 
side tripbosphates to remove the 3' overhang. The plasmid was recut with 
Xhol, and the Kpnl to XhoI fragment containing the Y end of the G gene 
was isolated. This fragment was figeted into a lllled-in BstEII to XhoI frag- 
ment containing the 5'  end of the v-sis gene, generating pMH54.  The 
v-$is~'7-239-G gene was constructed by the ligafion of a SalI to BstEII frag- 
ment containing the 5' portion of the v-sis  m gene into a SalI to BstER frag- 
ment from pMH107, containing the 3' end of the G gene and bacterial vector 
sequences. Finally,  the v-sis239NS-G  gene was constructed by the swapping 
of the SstI to BstElI fragment of the v-sis  Ns gene for the corresponding 
fragment of the v-sis:39-G gene. The respective v-sis-G genes were inserted 
into a murine leukemia virus (MuLV)-derived expression vector to allow 
for their expression in NIH3T3 ceils as previously described (Hannink and 
Donoghue, 1984),  and were inserted into pJCll9 (Sprague et al.,  1983) to 
provide for their expression in COS-I cells. 
Focus Assays and Viral Tfters 
The plasmid DNAs were introduced into NIH3T3  cells using the calcium 
phosphate coprecipitation method. The transfections were carded out in the 
presence of p836, a replication-competent DNA clone of MuLV (Hoffman 
et al., 1982). "l~ypically, 1 ~g of the plasmid DNA, 0.5 ~tg of p836,  and 20 
gg of sheared calf thymus DNA was precipitated with EtOH. The precipi- 
tate was resuspended in 400 ~tl of 2  x  Hepes (50 mM Hepes, 280 mM 
NaC1,  1 mM sodium phosphate, pH 7.0), and bubbled into 400 ttl of 0.25 
M  CaCI2.  The  calcium phosphate precipitate was allowed to  form  for 
30-45 min at room temperature before being added to NIH3T3 cells grown 
on 60-mm dishes. The precipitate was left on the cells overnight and the next 
day the ceils were refed with DME plus 10% calf serum. The cells were 
then split onto 4  ×  10-cm dishes, and allowed to become confluent. The 
cells were refed every 2-3 d with DME plus 10% calf serum, and scored 
for the presence of foci after 7-10 d. The conditioned media from the focus 
assays was collected and assayed for the presence of focus-forming virus. 
Serial dilutions of the conditioned media were added to NIH3"I3 cells in 60- 
mm dishes in the presence of 2 ttg/ml of polybrene. The virus was allowed 
to adsorb for 1 h, then the cells were washed and refed. The cells were al- 
lowed to become confluent and scored for the presence of foci after 5-7 d. 
COS-1 Transfections, Labelings, and 
Immunoprecipitations 
COS-1  cells (Gluzman,  1981) were transfected using the DEAE-Dextran 
method basically as described (Hannink et al.,  1986). 60-ram dishes con- 
taining COS-I cells at 70-80%  confluency were washed twice with Tris- 
saline (10 mM Tris 7.4, 150 mM NaCI). A solution of  the DNA in Tris-saline 
containing DEAE-dextran (2  ×  106 molecular mass) at 500 ttg/ml was 
added to the cells. The cells were kept at 37 ° for 15-20 rain before aspirating 
off  the DEAE-dextran solution. A 10% solution of  DMSO in Tris-saline was 
added to the plates for I rain, followed by two washes with Tris-saline. The 
cells were refed with DME plus 10% calf serum containing 100 ttM chloro- 
quine. After 2 h the chlorcquine was removed and the cells were allowed 
to grow for 48 h. 
The cells were labeled with 100 ttCi each of [3SS]cysteine and [3SS]me- 
thionine in  DME  lacking  cysteine and  methionine. The  usual  labeling 
period was 2 h, except for the pulse-cbase experiment in which a 30-rain 
labeling period was used before the chase with DME plus 10% calf serum. 
The cells were washed three times in Tris-sallne and lysed in 0.5 ml of Ripa 
buffer (10 mM sodium phosphate, pH 7.0, 150 mM NaC1, 1% Nonidet P-40, 
1%  sodium deoxycholate, 0.1%  SDS,  1%  Trasyiol). Cellular debris was 
pelleted and the lysate was aliquoted for immunoprecipitation. The immu- 
noprecipitate was allowed to form for 1 h on ice, and collected using fixed 
Staphylococcus  aureus  bacteria.  The pellet was washed three times with 
Ripa before resuspending in 1 ×  sample buffer (50 mM Tris, pH 6.8, 2% 
SDS, 20% B-mercaptoetbanol, 10% glycerol). For samples to be analyzed 
under nonreducing conditions, the B-nmreaptoethanol was omitted from the 
sample buffer. The immunoprecipitates were boiled for 2 rain before dec- 
trophoresis on 15 % SDS-polyacrylamide gels. The gels were processed for 
fluorography to visualize the radioactive proteins. For endoglycosidase H 
(Endo H) digestions, the immunoprecipitates were resuspended in 50 mM 
sodium phosphate, pH 6.1, 25 mM EDTA, 0.5 % Nonidet P-40, 0.5 % B-mer- 
captoethanol, and boiled for 1 rain.  10 mU of Endo H (Boehringer Mann- 
helm Biochemicals, Indianapolis, IN) was added and the reaction was al- 
lowed to proceed for 16-18 h before quenching in 2  x  sample buffer and 
analysis by SDS PAGE. Tunicamycin treatment was done for a period of 2 h 
before the labeling period at a concentration of 2 lxg/ml. Tunicamyein was 
included in the labeling media during the 2-h labeling period. 
Immunofluorescence 
cos-1 cells were grown on coverslips and transfected as described above. 
48  h  after transfection, the cells were fixed in 3 % paraformaldehyde in 
phosphate-buffered  saline. For external staining, the cells were reacted with 
a  1:1(30 dilution of rabbit antisera against the bacterially synthesized v-sis 
gene product, followed by a commercial rhodamine-conjngated goat anti- 
rabbit IgG. The cells were then permeabilized with Hepes-buffered saline 
containing 1% Triton X-100 and incubated with a 1:200 dilution of a mouse 
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the G protein (a gift of Tom Kreis, European Molecular Biology Laboratory, 
Heidelberg, Federal Republic of Germany). Biotinylated goat anti-mouse 
IgG was added, followed by fluorescein-labeled  streptavidin. The coverslips 
were then mounted in 90% glycerol-10% 1 M "Iris 8.0. NIH3T3  cells were 
infected at a multiplicity of  infection greater than one, and plated onto cover- 
slips the next day. The cells were processed for immunofluorescence as de- 
scribed above 2 d after infection. 
Results 
Construction of  Membrane-Anchor Mutants 
of the v-sis Gene 
To alter the cytological location of the v-sis  gene product 
from a secretory protein to a membrane bound protein, we 
have constructed several gene fusions between the v-sis gene 
and the G  gene of VSV (Fig.  1).  Our first concern was to 
characterize the dimer formation and biological activity of 
the v-sis gene product when anchored in the membrane. The 
minimal size of the biologically active v-sis gene product is 
88 amino acids, located within the PDGF-related portion of 
the v-sis gene product from residues 127 to 214 (Sauer et al., 
1986).  This truncated form of the v-sis gene product, when 
expressed with an NH2-terminal signal  sequence to direct 
its translocation across the membrane of the RER,  is fully 
active in transformation.  This protein contains 8 of the  10 
cysteine residues found in the v-sis ~  gene product, and ex- 
ists as a dimer when analyzed under nonreducing conditions. 
Further truncations of the v-sis gene product,  at either its 
COOH terminus or NH2 terminus, result in loss of biologi- 
cal activity and failure to dimerize. This minimal transform- 
ing region of the v-sis gene was included in all of the fusions 
we constructed  in  order  to  ensure  that the  resultant  gene 
product encoded sufficient v-sis sequences for dimerization 
and transformation. 
Second, we wanted to be able to alter the transport of the 
membrane-anchored v-sis protein such that transport to the 
cell  surface would be blocked.  It has been proposed that 
glycosylation  of transmembrane  proteins  is  an  important 
signal  for their transport to the cell  surface (Guan et al., 
1985).  The v-sis  TM  gene encodes a  single site for N-linked 
glycosylation at residues 93-95. We therefore used a mutant 
of the v-sis gene in which residues 58-126 have been deleted. 
This NH2-terminal mutant of the v-sis gene retains full bio- 
logical  activity  although  it  lacks  the  site  for  N-linked 
glycosylation (Sauer et al.,  1986).  This mutant v-sis gene 
was also fused to the transmembrane domain of G, with the 
expectation that its gene product would remain localized to 
an intracellular organelle, and fail to be transported to the 
cell  surface.  Since  alterations  in  the  transmembrane  and 
cytoplasmic tail of the G protein have been shown to affect 
its transport, we also constructed a gene fusion between the 
v-sis gene and a  mutant G  gene,  in which an arginine for 
isoleucine substitution was introduced into the hydrophobic 
transmembrane domain (Adams and Rose,  1985).  This mu- 
tant form of the G protein was shown to be a transmembrane 
protein, but its transport to the cell surface is blocked at some 
point in the Golgi apparatus. 
A total of six different gene fusions were constructed, as 
shown in Fig.  1. Four of these constructs differ in the v-sis- 
derived sequences present in the gene fusion, and three en- 
code altered transmembrane domains.  The v-$is239-G gene 
is the prototype of these gene fusions, containing a coding 
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Figure 1. Construction of the v-sis-G gene fusions. The six different 
gene fusions that were constructed are shown. The signal sequence 
of the v-sis gene and the transmembrane  domain of the G protein 
are indicated by small and large curliques,  respectively. The mini- 
mal transforming region of the v-sis gene is indicated by the cross- 
hatched  box.  The sites for N-linked  glycosylation (N-M-T) and 
for proteolytic processing (K-R) are indicated above the v-sis239-G 
fusion. These sites are present in the other fusions also, except as 
indicated by deletion in the v-sisIZT-239-G gene and by substitution 
in the v-sis239NS-G gene. The superscripted  number  indicates the 
amino acid codon in the respective gene at which the fusion was 
made. The scale is indicated on the bottom of the figure. 
region for 239 amino acids of the v-sis gene product fused 
in  frame to the coding  region for the 49  COOH-terminal 
amino acids of the VSV G gene.  The v-sisL~7-239-G gene fu- 
sion encodes a protein that lacks residues 58-126 of the v-sis 
gene product. The v-sis~39NS-G gene fusion encodes an Asn- 
Ser substitution for the Lys-Arg processing site at residues 
110-111. This results in the loss of the processing site and the 
addition of a new site for N-linked glycosylation. The paren- 
tal v-sis Ns gene is also fully biologically active in transfor- 
mation, in spite of the addition of a new N-linked oligosac- 
charide  to  its  gene product  at  residue  110. (Hannink  and 
Donoghue,  1986).  The v-sis223-G gene encodes the identical 
transmembrane domain fused into the v-sis  gene after the 
codon for amino acid 223.  Two other v-sis-G fusions were 
constructed  with altered anchor domains.  The v-sis239-G  m 
gene encodes the COOH-terminal 49 amino acids from the 
mutant G IR protein containing an isoleucine to arginine sub- 
stitution in the hydrophobic region.  The v-sis239-G  338 gene 
contains the first 239 codons of the v-sis gene fused to the 
COOH-terminal coding region of the G gene at codon 338, 
resulting in the addition of the COOH-terminal  117 amino 
acids of the G  protein to the v-sis gene product. 
Dimerization of the Transmembrane v-sis Gene Product 
We first wished to determine if the v-sis-G gene fusions en- 
coded proteins that were capable of dimerization. For these 
experiments we used a transient expression assay in COS-1 
cells, similar to that used by other investigators to study sig- 
nals involved in protein processing and transport (Rose and 
Bergmann,  1982;  Warren and Shields,  1985).  This system 
uses an expression vector in which the desired gene is ex- 
Hannink  and Donoghue  Cell Surface Expression  of v-sis Gene Products  2313 Figure 2.  Dimerization of the v-sis-G gene products. COS-I cells were transfected  with the following  v-sis-G genes inserted in pJCll9, 
an SV40 expression vector. Lanes 1-3 are from mock transfected cells; lanes 4-6 are from cells transfected with the v-sis239-G fusion; 
lanes 7-9 are from cells transfected with the v-sis223-G fusion; and lanes 10-12 are from cells transfected with the v-sis239-G33S fusion. Cell 
lysates were immunoprecipitated with antisera against the NH2terminus of the v-sis gene product, shown in lanes 1, 4,  7, and 10; or with 
NH2-terminal sera that was blocked with preineubation of peptide, lanes 2, 5, 8, and//;  or with antisera against the COOH terminus of 
the G protein, lanes 3, 6, 9, and 12. The immunoprecipitates were analyzed by SDS PAGE under reducing (A) and nonreducing (B) condi- 
tions, and the gel was fluorographed to visualize the labeled proteins. The arrows indicate the unprocessed immunoprecipitated proteins 
of 32, 30, and 45 kD in A. In B, the arrows indicate the v-sis-G dimers of 53, 49, and 82 kD. Molecular weights were determined by compari- 
son with commercially available protein standards. 
pressed from the SV40 late promoter (Sprague et al.,  1983). 
Three of the fusion genes were introduced into COS-1  cells 
and radiolabeled cell lysates were immunoprecipitated with 
antipeptide antiserum directed against the NH2 terminus of 
the  v-sis  gene  product,  or  with  antipeptide  antiserum  di- 
rected  against  the  COOH  terminus  of the  G  protein.  The 
v-sis239-G gene was found to encode a  protein of 32 kD that 
was specifically recognized by both antisera, and whose im- 
munoprecipitation  was blocked when the NH2-terminal  se- 
rum  was  incubated  with  an  excess  of peptide  before  im- 
munoprecipitation (Fig.  2 A, lanes 4-6).  The v-sis223-G and 
the  v-sis239-G  338  genes  were  also  found  to  encode  the  ex- 
pected  proteins  of 30  and  45  kD  (Fig.  2  A,  lanes  7-12). 
Smaller proteins were also immunoprecipitated by the anti-G 
serum from the lysates (Fig. 2 A, lanes 6, 9, and 12).  These 
proteins arise from proteolytic processing at residues 110-111 
of the v-sis gene product.  When  the identical  immunopre- 
cipitates were analyzed under nonreducing  conditions,  pro- 
teins  with  a  molecular  mass  consistent  with  dimerization 
were found (Fig. 2 B). The other v-sis-G gene products were 
also found to exist as dimers when analyzed under nonreduc- 
ing conditions (data not shown). This result indicates that the 
v-sis-G proteins  do  dimerize,  in  spite  of the  addition  of a 
transmembrane  domain,  and  therefore  are  potential  trans- 
forming gene products. 
Glycosylation of the Transmembrane v-sis 
Gene Product 
The v-sis gene encodes  a  single site  for the addition  of an 
N-linked  oligosaccharide,  an  Asn-Met-Thr  sequence  lo- 
cated  at  residues  93-95.  Previous  work  has  demonstrated 
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v-sis-G  gene product.  COS-1 
cells were transfected with the 
v-sis  ~9 gene (A) or the v-sis  239- 
G  gene  (B)  in the  SV40 ex- 
pression  vector.  The  cells 
were labeled for 30 min, then 
chased with unlabeled  media 
for  the  indicated  times.  Im- 
munoprecipitates  were  pre- 
pared and  treated  (+)  or not 
treated (-) with Endo H. The 
immunoprecipitates  were then 
analyzed under reducing  SDS 
PAGE conditions,  and  fiuo- 
rography  was  performed  to 
visualize  the  labeled  pro- 
teins.  The arrows indicate the 
v-sis 239 protein of 28 kD and 
the v-sis239-G protein of 32 kD 
(before  Endo H treatment). 
that the v-sis gene product is modified by the addition of a 
high mannose oligosaccharide during its translocation across 
the membrane of the RER.  To investigate the modification 
of the  transmembrane  forms of the  v-sis gene  product by 
glycosylation,  a  pulse-chase  experiment  was performed  in 
which the sensitivity of the oligosaccharide to Endo H  was 
examined.  The transfected COS-1 cells were labeled for 30 
min,  then the radiolabel  was chased for periods of 30,  60, 
and  120 min.  The v-sis239-G gene product remained  sensi- 
tive to Endo H during the labeling period and the chase (Fig. 
3, lane B), as did the v-sis  ~39 gene (Fig. 3, lane A). The pat- 
tern of glycosylation of the other v-sis-G gene products was 
similar.  The  v-sis239NS-G gene,  containing  two  sites  for 
N-linked  glycosylation,  was  also  found  to  remain  sensi- 
tive to Endo H  during  a  2-h chase (data not shown). 
To  confirm  the  absence  of  any  N-linked  oligosaccha- 
rides on the v-sisf27-239-G protein,  COS-1 cells expressing the 
fusion genes were treated with tunicamycin before and dur- 
ing the  labeling  period.  The inhibition  of N-linked  oligo- 
saccharide formation resulted in a shift of the v-sis223-G and 
the  v-sis239-G  338  proteins  to  a  lower  molecular  mass  form 
(Fig. 4,  lanes 1-4), while no difference in the v-sisI27-239-G 
protein  was detected  (Fig.  4,  lanes  5  and 6). 
Cellular Localization of the Transmembrane v-sis 
Gene Product 
To determine  the cellular  localization  of the  v-sis-G  gene 
products,  double-label  immunofluorescence  experiments 
were  performed.  In these  experiments,  transfected  COS-1 
cells were fixed, then incubated with anti-sis serum followed 
by  rhodamine-labeled  conjugate  before  permeabilization. 
Hannink and Donoghue Cell Surface Expression of v-sis Gene Products  2315 Figure  4.  Tunicamycin treatment  of the  v-sis-G gene  products. 
COS-1 cells were transfected with the v-sis-G gene in the SV40 ex- 
pression vector. The cells were treated (lanes 2, 4, and 6), or not 
treated (lanes 1, 3, and 5) with tunicamycin at a concentration of 
2 ~g/ml for 2 h before and during the labeling period.  Cell lysates 
were immunoprecipitated  with the anti-sis serum and the immu- 
noprecipitates  were analyzed  under  reducing  SDS  PAGE condi- 
tions,  followed by fluorography to visualize the labeled proteins. 
The v-sis-G genes used are as follows: the v-sis223-G gene (lanes 1 
and 2); the v-sis239-G  338 gene (lanes 3 and 4); and the v-sis127-239-G 
gene (lanes 5 and 6). The arrows indicate the glycosylated proteins 
of 30 and 45 kD that are encoded by the v-sis223-G and the v-sis  239- 
G  338 genes, and the nonglycosylated protein of 22 kD encoded by 
the v-sis  ~27 239-G gene. 
After permeabilization,  the  cells  were incubated  with  the 
anti-G peptide serum, followed by fluorescein-labeled con- 
jugate.  The v-sis239-G  gene product was found to be trans- 
ported  to  the  cell  surface  (Fig.  5,  C  and  D),  as  was  the 
v-sis223-G  gene product (data not shown).  The v-sislZT-239-G 
gene product was also found to be transported to the cell sur- 
face in  spite of its lack of N-linked glycosylation (Fig.  5, 
E and F). The intensity of cell surface staining with the anti- 
sis serum was variable in these cases, indicating that not all 
of the cells transported the v-sis-G gene products equally. 
However, in the case of the v-sis239NS-G gene product,  (Fig. 
5,  G and H), little cell to cell variation was observed, and 
the intensity of cell surface staining was consistently greater. 
Cell  surface  staining  of  cells  expressing  the  v-sis239-Gm 
gene (Fig.  5,  I  and J),  and the v-sis239-G 338 gene (data not 
shown)  was not found. 
The  cell  surface transport of these proteins  in  NIH3T3 
cells was also examined by double-label indirect immunoflu- 
orescence. Acutely infected NIH3T3 cells were found to ex- 
press  the  v-sis239NS-G protein  on  the  cell  surface  (Fig.  6) 
when  stained  with  anti-sis  serum.  NIH3T3  cells  infected 
with the other constructs used in this study were not found 
to express detectable levels of the sis protein at the cell sur- 
face, although internal staining with either the anti-sis or the 
anti-G  sera  displayed  a  similar  Golgi  staining  (data  not 
shown). These results are in agreement with the immunoflu- 
orescence experiments in COS-1 cells, where the v-sis  239Ns- 
G protein was found to have the highest level of cell surface 
expression. Lower levels of protein expression in the infected 
NIH3T3 cells as compared with the transient expression as- 
says in COS-1 cells is the most likely explanation for the in- 
ability to detect cell surface expression of the  other sis-G 
proteins  in  NIH3T3  cells.  Alternatively,  the  v-sis239NS-G 
protein may have a slower rate of turnover or internalization 
than the other fusion proteins,  thereby increasing the level 
of detectable cell surface protein. 
Transforming Activity of the Transmembrane v-sis 
Gene Product 
To assay the  fusion genes for their biological activity, the 
respective fusion genes were inserted into a  retroviral vec- 
tor to provide for expression in  NIH3T3 cells.  The resul- 
tant plasmids were introduced into NIH3T3 cells using the 
calcium  phosphate  coprecipitation  method.  Since  the  ex- 
pression  vector  is  replication-defective,  a  DNA  clone  of 
replication-competent MuLV was included  in the transfec- 
tions to allow for viral spread and  rescue.  The v-sis239-G, 
v-sis239NS-G, and the v-sis~r-239-G  genes were found to have 
comparable  biological  activities  only  slightly  lower  than 
v-sis  wt gene.  (Table I). The v-sis223-G  gene and the v-sis  z39- 
G m gene were found to have further reduced levels of focus 
formation, while the v-sis239-G 338 gene was found to be bio- 
logically inactive. In all cases the conditioned media of the 
focus assays was found to contain rescuable focus-forming 
virus at levels consistent with the biological activities of the 
respective genes. 
Discussion 
We have constructed  a  series of gene fusions between the 
v-sis gene and the G  gene of VSV.  The gene products en- 
coded by these v-sis-G fusions result in the conversion of the 
v-sis gene product from a  secretory protein to an  integral 
membrane protein.  The membrane-anchored v-sis-G gene 
products exist as dimers when analyzed under nonreducing 
conditions. They are proteolytically processed and glycosyl- 
ated  in  the  same  manner  as  the  v-sis  wt  gene.  By  these 
criteria,  the  membrane-anchored  v-sis  gene  products  are 
properly folded into a  native conformation.  Certain of the 
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one  that  lacks  the  site  for  N-linked  glycosylation,  were 
transported to the cell surface. Differences among the gene 
fusions were also found in their ability to induce focus for- 
mation in NIH3T3 cells. 
Implications for Protein Transport 
An important difference between these results and the results 
of previous experiments that examined protein-encoded sig- 
nals for cell surface transport is the lack of a requirement of 
glycosylation for cell surface transport. This is demonstrated 
by the fact that the nonglycosylated v-sis127-239-G gene prod- 
uct was transported to the cell surface equally as well as the 
glycosylated v-sis239-G gene product.  One explanation for 
this difference may be the importance of the native structure 
of the protein for proper transport. Initial evidence for the 
role of native protein structure in protein transport came 
from the analysis of ts mutants of the G protein, in which 
the defect responsible for protein transport has been shown 
to be a single amino acid change of phenylalanine to serine 
at residue 204 (Gallione and Rose,  1985).  In this case, the 
possible denaturation of the protein at the restrictive temper- 
ature was invoked as an explanation for its defect in trans- 
port.  In this  study,  the membrane-bound v-sis-G proteins 
were found to possess a native structure, as judged by both 
their capacity to dimerize and by their ability to induce focus 
formation in NIH3T3 cells.  A  limitation of other studies, 
which have implicated glycosylation as a determinant for cell 
surface transport, was the inability to assay the hybrid pro- 
teins  for proper  folding  into  a  native conformation.  Our 
results suggest that it is not glycosylation per se, but rather 
the effect of glycosylation on protein structure that is impor- 
tant for cell surface transport. The importance of glycosyla- 
tion for the formation and maintenance of the native struc- 
ture of proteins needs to be investigated further. 
The importance of the nature of the oligosaccharide for 
proper transport is not known. It has been demonstrated with 
specific glucosidase I inhibitors that cell surface transport of 
the v-fms protein can be blocked within the RER/Golgi com- 
partment. (Nichols et al.,  1985).  Therefore, failure to pro- 
cess the high mannose oligosaccharide that is added during 
translocation to a  specific complex type can block further 
transport of the protein. It is not known if the high mannose 
oligosaccharide of the v-sis gene product is subject to the ac- 
tion of glucosidase I upon transit from the RER to the Golgi. 
However, the oligosaccharide that is added to the v-sis  ~ or 
the v-sis-G proteins is not modified to the complex type dur- 
ing a 2-h chase period. Yet these proteins are transported to 
the cell surface, demonstrating that modification of the high 
mannose oligosaccharide to the complex type is not a general 
requirement for cell surface transport.  The differences re- 
garding the importance of oligosaccharide modification for 
transport suggest that there are multiple pathways of trans- 
port through the Golgi.  The nature  of the discrimination 
among proteins for these various pathways is not known at 
this time, but is clearly of importance in the understanding 
of protein-sorting mechanisms. 
Implications for Transformation by v-sis 
The v-sis gene product is able to transform cells by virtue of 
its ability to activate the PDGF receptor in an autocrine fash- 
ion (Huang et al., 1984). Cells transformed by the v-sis gene 
Table L Biological Activities of the v-sis-G Fusion Genes 
Gene fusion  Focus assay  Titer 
FFU/pmol  FFU/ml 
v-sis  TM  1.0  X  10  4  3.5  x  10  6 
v-sisZ39-G  4.7  ×  10  3  1.0  x  10  5 
v-sisJ27-239-G  3.7  )<  10  3  1.1  x  105 
v-$is239NS-G  4.8  ×  10  3  1,5  ×  105 
v-sis2Z3-G  5.0  x  102  3.0  )<  103 
v-sisZ39-O m  4.1  x  10  2  2.0  ×  103 
v=sis239-G  338  <1.0  ×  101  <5.0  ×  l0 t 
The v-sis-G genes were inserted into a MuLV-derived retroviral vector and in- 
troduced into N1H3T3 cells using the calcium phosphate coprecipitation tech- 
nique. The biological activities of the respective v-sis-G fusion genes are given 
in  focus-forming units  per  picomole  (FFU/pmole)  of  transfected  plasmid 
DNA. The levels of rescuable focus-forming virus that was detected in the con- 
ditioned media of the focus assays are given in focus-forming units per mil- 
liliter (FFU/ml) of conditioned media. The v-sis  TM gene was included in these 
assays as a  representative deletion mutant (Hannink et al.,  1986). 
secrete a mitogenic factor into the media; this protein has 
been identified as the 20-kD  protein resulting from NH2- 
terminal processing (Garret et al., 1984). This secreted form 
has been shown to cause autophosphorylation of the PDGF 
receptor (Owen et al., 1984; Garret et al., 1984). Since exog- 
enous PDGF is not sufficient for transformation (Assoian et 
al.,  1984),  it is not clear how the endogenous synthesis of 
a PDGF-related growth factor leads to transformation. The 
simplest explanation is that chronic stimulation of the PDGF 
receptor by the v-sis gene product results in transformation. 
Antibodies to PDGF have been shown to inhibit transforma- 
tion by SSV,  suggesting that a  secreted or a cell surface- 
associated v-sis gene product is responsible for transforma- 
tion (Johnsson et al., 1985). An alternative possibility is that 
the  site of interaction of the v-sis  gene product with  the 
PDGF receptor may be important (Huang et al.,  1984; Hel- 
din and Westemark, 1984). When PDGF binds to the PDGF 
receptor and stimulates its tyrosine kinase-associated activ- 
ity, it does so on the outside of the cell. In contrast, the v-sis 
gene product can potentially interact with the PDGF recep- 
tor inside the cell, during transport through the Golgi and 
secretory  vesicles.  In  support  of  this  model,  an  SSV- 
transformed cell line that does not secrete a mitogenic factor 
into the media, and whose growth is not affected by the addi- 
tion of anti-PDGF IgG, is still able to form tumors in nude 
mice. The tumor size of different SSV-transformed cell lines 
did correlate with the level of secreted mitogen (Huang et al., 
1984). Therefore, at least a portion of the biological activity 
of the v-sis gene product may be mediated by an intracellular 
form. 
In the results presented here, we have found differences in 
both the biological activities of the v-sis-G genes and in the 
level of cell surface transport of their respective proteins. In 
particular,  the  v-sis239-G gene  and  others  with  identical 
COOH-terminal coding regions were found to have similar 
levels of biological activity. Their proteins were all found to 
be transported to the cell surface. This is in contrast to the 
absence of detectable cell surface transport of the v-sis  239- 
G IR and the v-sis239-G 338 proteins. The genes encoding these 
latter proteins were also found to have reduced or nonexistent 
levels of focus-forming activity.  This  correlation suggests 
that cell surface expression of the membrane-anchored v-sis 
gene products is required for transformation. The v-sis223-G 
Hannink and Donoghue Cell Surface Expression  of v-sis  Gene Products  23 17 Figure  5.  Indirect  immunofluores- 
cence of the v-sis-G gene products. 
COS-1 cells were transfected with the 
following v-sis-G genes in the SV40 
expression vector and processed  for 
immunofluorescence as described in 
Materials  and  Methods.  A  and  B 
show the inside and outside staining, 
respectively,  of  mock-transfected 
cells; Cand D are the inside and out- 
side staining of cells transfected with 
the v-sis239-G gene; E  and F  are the 
inside  and  outside  staining  of cells 
transfected  with  the  v-sis~27-239-G 
gene; G and Hare the inside and out- 
side  staining  from  cells transfected 
with  the  v-sis239NS-G gene;  I  and  J 
(right page)  are the inside and out- 
side staining of cells transfeeted with 
the v-sis239-~ R gene.  An  automatic 
exposure  setting of 3,200  was  used 
for the inside staining,  and a  setting 
of  1,600  was  used  for  the  outside 
staining.  Bar in J,  10 Ixm. 
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has a  reduced level of focus formation. The reason for this 
is not clear. This protein has a shorter distance between the 
minimal transforming region and the membrane anchor do- 
main than the v-sis239-G proteins. This may affect either the 
ability of the v-sis223-G protein to interact directly with the 
PDGF  receptor or  the  release of a  PDGF-related protein 
from the membrane-anchored protein. 
Since transformation by the v-sis gene product is mediated 
through autocrine stimulation of the PDGF-receptor, one in- 
terpretation of our results is that a transforming interaction 
can  occur  between  two  integral  membrane  proteins.  The 
principal objection to this interpretation is the possibility that 
the transmembrane form of the v-sis-G gene product is not 
biologically  active,  but  that  a  small  amount  of a  PDGF- 
related protein is released into the extracellular matrix in- 
stead, allowing its interaction with the receptor and conse- 
quent transformation. 
A form of the G protein, Gs, which is secreted from VSV- 
infected  cells,  has  been  identified.  This  protein  has  been 
shown to be formed during or shortly after translation both 
in  vivo and  in  vitro,  and  its  production  in  vitro  was  not 
affected by the presence of protease inhibitors. These results 
suggest  that  the  G~  protein  arises  from  an  altered  viral 
mRNA specifically encoding Gs, although  such an altered 
mRNA has not been detected in VSV-infected cells. Alterna- 
tively, this secreted form may arise from a protein that lacks 
the transmembrane domain as a result of a reading frameshift 
of the G mRNA (Graeve et al.,  1986).  In view of the differ- 
ences in the levels of focus formation that was found, we con- 
sider it unlikely that a  similar v-sis-G~  protein is responsi- 
ble for the observed biological activities of the v-sis-G genes. 
The other mechanism whereby a v-sis gene product could 
be  released  into  the  extracellular  media  is  by  COOH- 
terminal proteolysis of the v-sis-G fusion protein. The v-sis 
gene product has been reported to undergo COOH-terminal 
processing as well as NHz-terminal processing, resulting in 
the formation of a PDGF-related protein that is detected as 
a  24-kD  dimer under  nonreducing  conditions  (Robbins et 
al.,  1983).  In our  previous  studies  of v-sis-encoded  gene 
products, particularly those with COOH-terminal deletions, 
we  were  unable  to  detect  any  evidence  for  the  proposed 
COOH-terminal processing event (Hannink and Donoghue, 
1986;  Hannink, Sauer, and Donoghue,  1986).  Thus the site 
and the biological importance of this COOH-terminal pro- 
cessing  event  is  not  known.  COS-1  cells  expressing  the 
v-sis239-G gene do  not  secrete a  mitogenic factor into  the 
media (data not shown).  These results argue that a  PDGF- 
related protein is not released from the v-sis-G proteins into 
the media as a  result of COOH-terminal proteolysis. How- 
ever, the sensitivity of the mitogen assay is not sufficient to 
detect low levels of secreted protein that nonetheless may be 
responsible for transformation when chronically produced in 
an  autocrine  fashion.  Such  a  protein  may  not  be  freely 
secreted into the media in a manner that allows its detection 
in  assays performed on  serum-free conditioned  media.  In 
this respect, it is notable that considerably higher levels (50- 
fold) of anti-PDGF IgG was required to inhibit the growth 
of SSV-transformed cells than was necessary for the clear- 
ance of mitogenic activity from the conditioned media col- 
lected from these cells (Johnsson et al.,  1985).  In addition, 
it has been demonstrated that only a  low level of the total 
mitogenic activity of SSV-transformed cells is released free- 
ly into the media, the remainder consisting of intracellular 
or plasma membrane-associated material  (Robbins et al., 
1985). Therefore, we can not rule out the possibility that the 
observed levels of focus formation of the v-sis-G genes are 
due to the presence of low levels of proteolytic release of a 
v-sis  protein  from the  membrane-anchored v-sis-G  mole- 
cule.  It will  be of interest  to determine the  effect of anti- 
PDGF IgG on the transformed phenotype and growth char- 
acteristics of cells transformed by the v-sis-G genes. 
Other Transmembrane Growth Factor-related Proteins 
In these experiments we have constructed biologically active 
transmembrane mutants of the v-sis gene product.  Recent 
evidence has come to light that similar transmembrane forms 
of growth  factor-related  proteins  may  have  an  important 
physiological role. In particular, the precursor to the epider- 
mal growth factor (EGF) molecule has been hypothesized to 
have a transmembrane structure oriented in the same fashion 
as the v-sis-G proteins reported here. The importance of the 
transmembrane nature of the EGF precursor is not known, 
although several hypotheses have been advanced on the basis 
of homology between the EGF precursor and other proteins. 
These proteins include the low density lipoprotein receptor 
(Russell et al.,  1984), and the proteins encoded by the Notch 
Hannink and Donoghue  Cell Surface Expression  of v-sis  Gene Products  2319 Figure 6.  Indirect immunofluorescence in NIH3T3 cells.  NIH3T3 cells were  infected with the v-sis2~gNS-G/MuLV virus stock or with the 
MuLV virus stock (Mock).  The top photos show the outside staining with the anti-sis serum, the middle show the internal staining with 
the anti-G serum, and the bottom photos are the phase-contrast images of the same cells. An automatic exposure setting of 800 was used 
for these pictures.  Bar,  10 I.tm. 
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by  the  lin  locus  of Caenorhabditis  elegans  (Greenwald, 
1985). The basis for this homology is the spacing of six cys- 
teine residues, which in the case of EGF, have been shown 
to be involved in intramolecular disulfide bonding. These 
proteins have up to 36 repeated units of an EGF-like domain, 
followed by a transmembrane domain and a variable intracel- 
lular domain. The Notch and lin proteins have been proposed 
to have a role in determining the fate of cells in a developing 
organism. Whether they function in an autocrine fashion by 
stimulation of the receptor on the same cell or in a paracrine 
fashion by either proteolytic release of an EGF-like factor or 
by interaction with a receptor on adjacent cells is not known. 
Our demonstration that membrane-anchored forms of the 
v-sis gene product are biologically active suggests that the 
transmembrane forms of these growth factor-related mole- 
cules may have physiological roles.  Additional support of 
this comes from the cell autonomous behavior of the Notch 
locus in mosaic individuals, indicating that the effect of the 
Notch protein is mediated within the local environment of  the 
cell, not as a widespread diffusable factor (Bender,  1985). 
The plasma membrane has long been regarded as the site 
at which a cell receives signals from the extracellular matrix. 
A  tremendous variety of signals interact with cell surface 
receptors,  including mitogenic  signals,  growth  inhibitory 
signals, and signals for the release of stored intracellular 
molecules. Perhaps the plasma membrane should also be re- 
garded as a site for the reception of signals originating from 
the cell's interior, encoded by the cell's own genes. 
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